Forte Biosciences’ clinical trial for a potential Coeliac disease treatment is now recruiting participants in Mackay through the Coral Sea Clinical Research Institute (CSCRI).
The clinical trial follows results from Forte Biosciences’ FB102 Phase 1B study, which showed encouraging outcomes for Coeliac disease patients and highlighted the potential for new therapies.
Dr James Daveson Founder and Director of CSCRI, Gastroenterologist and Founder of endosQ, and Primary Investigator for a range of clinical trials at CSCRI, is leading efforts to evaluate novel treatments that moderate the immune response to gluten for people living with Coeliac disease.
“We recently held an information evening, in conjunction with Dr Paul Wagner, CEO and Founder of Forte Biosciences, to empower those living with Coeliac disease by offering a deeper understanding of their condition and the promising advancements in treatment currently underway,” Dr Daveson said.
Coeliac disease is a chronic autoimmune disorder affecting about 1.3% of the global population, more than 315,000 Australians, including around 80,000 people in regional Queensland.
With a career dedicated to improving health outcomes in Queensland, Dr Daveson has contributed to the discovery of new diagnostics and advanced research into Coeliac disease and advocating for improved rates of diagnosis. His work also addresses health equity challenges in regional Australia.
Register to participate in the upcoming clinical trial at https://coralseaclinical.com/current-studies/coeliac-disease-forte-bio/ or contact CSCRI on 1800 69 27 27.
Publishers Indemnity. Any individual or entity that places advertising, supplies copy material, or submits editorial content to Core Life Publishing agrees and undertakes to ensure that all such material:- Does not infringe upon any copyright, trademark, or other intellectual property rights;- Is free from any content that could be considered defamatory, libelous, or slanderous;- Does not infringe upon any rights related to privacy or breach of confidence;- Contains no obscene, indecent, or otherwise unlawful material;- Complies fully with the Trade Practices Act and all other applicable laws, regulations, or statutes.Furthermore, by submitting or placing such material, these individuals or entities agree to indemnify and hold harmless the publisher, Core Publishing and Events Pty Ltd, and/or its agents from and against any and all investigations, claims, demands, liabilities, damages, costs, or judgments arising out of or in connection with the material provided. All material is believed to be accurate at the time of printing and remains the copyright of Core Publishing and Events Pty Ltd.
© 2024 Mackay and Whitsunday Life Pty Ltd.
